The UK government is not slow to refer to “new freedoms” that allow it to flex its post-Brexit muscles to simplify national regulations or expedite market access for businesses – even if the outcomes are as yet barely visible.
Soon, however, there will be a real opportunity in the medtech sector for the UK to realize an actual post-EU...